Overexpression pattern, function, and clinical value of proteasome 26S subunit non-ATPase 6 in hepatocellular carcinoma

doi:10.5306/wjco.v16.i2.99839

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (976)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-11) series, Tables (1-1) series.

Item

Count

PDF

HTML

287

Figures (1-11)

114

Tables (1-1)

111

Sum=530

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

104

Download

201

Sum=305

Publishing Process of This Article

Item

Count

Browse

Download

Sum=109

Feb 24, 2025 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Clin Oncol. Feb 24, 2025; 16(2): 99839
Published online Feb 24, 2025. doi: 10.5306/wjco.v16.i2.99839

Full Size Figure Download Figure

Figure 7 Evaluation of the potential molecular biological mechanisms of proteasome 26S subunit non-ATPase 6 in hepatocellular carcinoma tissues. A: Gene Ontology enrichment analysis; B: Kyoto Encyclopedia of Genes and Genomes enrichment analysis.

Citation: Zhou SS, Ye YP, Chen Y, Zeng DT, Zheng GC, He RQ, Chi BT, Wang L, Lin Q, Su QY, Dang YW, Chen G, Wei JL. Overexpression pattern, function, and clinical value of proteasome 26S subunit non-ATPase 6 in hepatocellular carcinoma. World J Clin Oncol 2025; 16(2): 99839
URL: https://www.wjgnet.com/2218-4333/full/v16/i2/99839.htm
DOI: https://dx.doi.org/10.5306/wjco.v16.i2.99839